One project is called PADDINGTON, where researchers of Siena Biotech in Italy have developed a new compound that binds to the toxic protein of Huntington’s Disease and disables it. This could slow down the progression of the disease, and preliminary clinical tests are underway.
The second research endeavour is called NEUROSTEMCELLS, where a team in Milan led by Professor Elena Cattaneo studies how the neurons in Huntington’s patients are lost. The researchers want to use stem cells to grow exactly those neurons which are being lost by the disease. Their vision: to use these lab-grown neurons one day for experimental transplants.
Share this Video
Related Videos In Movement Disorders
EAN 2020 – Time for Action. Predict. Prevent. Repair.
EAN President, Prof. Claudio Bassetti invites you to participate in the EAN 2020 congress. You can register for the virtual congress free-of-charge here. It’s a fantastic opportunity for everyone in the neurology community to benefit from the possibility of education, scientific news and best practice exchange from the comfort of home. Be sure to visit our EAN […]
Angela Vincent, MDS 2019 – Autoimmune movement disorders
It was an absolute pleasure to meet with Angela Vincent, Emeritus Professor of Neuroimmunology at the University of Oxford. Until 2016 she led the clinical and research laboratory at Oxford specialising in antibody-mediated neurological diseases. Despite not being a neurologist herself, she spoke from long experience of helping to identify and characterise pathogenic antibodies in […]
Hélio AG Teive, MDS 2019 – Spinocerebellar ataxia
MDS Congress Scientific Program Committee member, Hélio AG Teive (Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil) kindly talked to us about spinocerebellar ataxia and its geographical diversity. Questions 1. How does spinocerebellar ataxia differ from other ataxias? (0:05) 2. In what regions is spinocerebellar ataxia found? (0:26) 3. What is the reason for […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!